Combined hepatocellular carcinoma-cholangiocarcinoma: Report of MR appearance in eleven patients

被引:41
|
作者
de Campos, Rafael O. P. [1 ]
Semelka, Richard C. [1 ]
Azevedo, Rafael M. [1 ]
Ramalho, Miguel [1 ]
Heredia, Vasco [1 ]
Armao, Diane M. [1 ,2 ]
Woosley, John T. [2 ]
机构
[1] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA
关键词
combined hepatocellular-cholangiocarcinoma; mixed; magnetic resonance findings; MR appearance; primary liver tumor; INTRAHEPATIC CHOLANGIOCARCINOMA; COMPUTED-TOMOGRAPHY; PROGNOSTIC-FACTORS; CT; LIVER; TRANSPLANTATION; METASTASES; PATTERNS; FEATURES;
D O I
10.1002/jmri.23754
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To describe the magnetic resonance imaging (MRI) appearance of hepatic combined hepatocellular-cholangiocarcinoma (cHCC-CC) in 11 patients. Materials and Methods: The database of the Department of Pathology was cross-referenced with the MRI database to identify patients with confirmed cHCC-CC who had undergone MRI. Eleven consecutive patients were included (seven female, mean age 57.6 years). All patients were Caucasian. Five of 11 had a clinical history of chronic liver disease. Two radiologists retrospectively analyzed the images in consensus. Results: cHCC-CC was a single mass in 10/11 patients. Margins were well-defined in 6/11. All tumors showed heterogeneous hyperintensity on T2. On postcontrast imaging, 6/11 showed early ring-enhancement (four noncirrhotic), with progressive enhancement in central portions, and 5/11 patients showed a diffuse heterogeneous early enhancement. Three of these five were cirrhotic and displayed partial washout with portions of contrast retention on later phases. Other findings included: late capsule enhancement (two patients), biliary dilatation (one), venous invasion (three), lymphadenopathy (six), and findings of cirrhosis (five). Conclusion: cHCC-CC presents most commonly as a single mass. Five of 11 had MR findings of cirrhosis. Clues to the diagnosis were moderately high signal on T2, portions of tumor that show progressive enhancement/contrast retention, and frequent lack of capsule. Early enhancement patterns included early ring-enhancement and diffuse heterogeneous enhancement. J. Magn. Reson. Imaging 2012;36:11391147. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:1139 / 1147
页数:9
相关论文
共 50 条
  • [1] Management of Combined Hepatocellular Carcinoma-Cholangiocarcinoma
    Ju Dong Yang
    Lewis R. Roberts
    Current Hepatology Reports, 2018, 17 (4) : 385 - 391
  • [2] Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
    Yoon, Young-In
    Hwang, Shin
    Lee, Young-Joo
    Kim, Ki-Hun
    Ahn, Chul-Soo
    Moon, Deok-Bog
    Ha, Tae-Yong
    Song, Gi-Won
    Jung, Dong-Hwan
    Lee, Jong-Woo
    Hong, Seung-Mo
    Yu, Eun Sil
    Lee, Sung-Gyu
    JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (02) : 411 - 420
  • [3] Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update
    Rossner, Florian
    Sinn, Bruno Valentin
    Horst, David
    CANCERS, 2023, 15 (02)
  • [4] Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
    Young-In Yoon
    Shin Hwang
    Young-Joo Lee
    Ki-Hun Kim
    Chul-Soo Ahn
    Deok-Bog Moon
    Tae-Yong Ha
    Gi-Won Song
    Dong-Hwan Jung
    Jong-Woo Lee
    Seung-Mo Hong
    Eun Sil Yu
    Sung-Gyu Lee
    Journal of Gastrointestinal Surgery, 2016, 20 : 411 - 420
  • [5] Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma
    Groeschl, Ryan T.
    Turaga, Kiran K.
    Gamblin, T. Clark
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (06) : 608 - 612
  • [6] Combined hepatocellular carcinoma-cholangiocarcinoma: A misdiagnosed case preoperatively
    Ding, Lei
    Hu, Wang
    Wu, Qingrong
    Hu, Zhiqiang
    Zhang, Jianhong
    Jiang, Lihui
    Hu, Zeming
    JGH OPEN, 2021, 5 (06): : 720 - 721
  • [7] MR radiomics to predict microvascular invasion status and biological process in combined hepatocellular carcinoma-cholangiocarcinoma
    Xiao, Yuyao
    Wu, Fei
    Hou, Kai
    Wang, Fang
    Zhou, Changwu
    Huang, Peng
    Yang, Chun
    Zeng, Mengsu
    INSIGHTS INTO IMAGING, 2024, 15 (01):
  • [8] An exceptional response to immunotherapy doublet in combined hepatocellular carcinoma-cholangiocarcinoma
    Tahover, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] Combined hepatocellular carcinoma-cholangiocarcinoma: Diagnosis and outcome of transplantation.
    Fahmy, Ahmed E.
    Murakami, Takahiro
    John, Devon
    Diflo, Thomas
    Morgan, Glyn
    Campbell, Donna
    Teperman, Lewis
    LIVER TRANSPLANTATION, 2007, 13 (06) : S75 - S76
  • [10] Is it necessary to distinguish between combined hepatocellular carcinoma-cholangiocarcinoma with less than 10% of cholangiocarcinoma components versus hepatocellular carcinoma?
    Zhou, Changwu
    Yang, Chun
    Zeng, Mengsu
    HEPATOLOGY INTERNATIONAL, 2024,